Skip to main content

Advertisement

Log in

Long-acting octreotide in the treatment of diarrhea after pelvic pouch surgery

  • SHORT COMMUNICATION
  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

Abstract

After pelvic pouch surgery (restorative proctocolectomy), periodic or continuous diarrhea is common. Distressing diarrhea may be triggered by pouchitis, cuffitis or an anastomotic stricture. Medical therapy with loperamide or diphenoxylate is often unsatisfactory even after the correction of the underlying problem. Seven patients, who earlier had undergone restorative proctocolectomy, were treated with a standard dose of 10 mg of long-acting octreotide (Sandostatin LAR) for prolonged and distressing diarrhea which had not responded to conventional medication. Five of the patients had complete relief of diarrhea. The effect lasted for at least two months after a single dose. Two patients did not respond. No sideeffects were reported. Long-acting octreotide is effective in the treatment of severe diarrhea in patients after pelvic pouch surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Gullichsen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gullichsen, R. Long-acting octreotide in the treatment of diarrhea after pelvic pouch surgery. Tech Coloproctol 10, 346–349 (2006). https://doi.org/10.1007/s10151-006-0306-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-006-0306-x

Key words

Navigation